Ramirez Sylvia Paz B, Hsu Stephen I-Hong, McClellan William
Center for Prevention and Research, National Kidney Foundation Singapore, Singapore.
Kidney Int Suppl. 2003 Feb(83):S61-5. doi: 10.1046/j.1523-1755.63.s83.13.x.
The National Kidney Foundation Singapore (NKFS) provides subsidized dialysis care to approximately 70% of the country's total end-stage renal disease (ESRD) population, based entirely on charitable donations. Because of the exponential increase in prevalent dialysis patients receiving care through the NKFS' chronic dialysis program, and with the anticipated epidemic rise in incident ESRD patients, an accelerated comprehensive strategy for the prevention of renal and its associated chronic diseases was developed. Presented is the NKFS' public health plan, which incorporates primary, secondary and tertiary approaches to the prevention of chronic kidney disease. Components of this comprehensive strategy include: screening populations at risk for the development and progression of renal disease, the documentation of existing standards of care for chronic diseases associated with renal disease, and the institution of disease management programs that facilitate the systematic management of patients with chronic diseases that lead to ESRD, including the development of community-based "Prevention Centers." Finally, longitudinal follow-up of the participating population is being performed in order to provide benchmarks for improvement and to determine future directions of the program. Such long-term monitoring also will facilitate the establishment of its efficacy in improving clinical outcomes, reducing the cost of care, and delaying the development and progression of chronic kidney disease.
新加坡国家肾脏基金会(NKFS)完全基于慈善捐赠,为该国约70%的终末期肾病(ESRD)患者提供补贴透析治疗。由于通过NKFS慢性透析项目接受治疗的透析患者数量呈指数级增长,且预计新发ESRD患者数量将呈流行趋势上升,因此制定了一项加速的预防肾脏及其相关慢性病的综合战略。本文介绍了NKFS的公共卫生计划,该计划纳入了预防慢性肾病的一级、二级和三级方法。这一综合战略的组成部分包括:对有肾病发生和进展风险的人群进行筛查,记录与肾病相关的慢性病现有护理标准,并设立疾病管理项目,以促进对导致ESRD的慢性病患者进行系统管理,包括建立社区“预防中心”。最后,对参与人群进行纵向随访,以便为改进提供基准并确定该项目的未来方向。这种长期监测还将有助于确定其在改善临床结局、降低护理成本以及延缓慢性肾病的发生和进展方面的效果。